Literature DB >> 7749930

Cytokines inhibit fatty acid oxidation in isolated rat hepatocytes: synergy among TNF, IL-6, and IL-1.

V Nachiappan1, D Curtiss, B E Corkey, L Kilpatrick.   

Abstract

We have developed an in vitro rat hepatocyte model in which cytokines inhibit fatty acid oxidation. Cytokine administration resulted in decreased fatty acid oxidation, ketone body production and acetyl CoA/CoA ratios. The inhibitory effects of TNF on fatty acid oxidation were enhanced by either IL-1 or IL-6. TNF (20 U/ml) + IL-6 (30 ng/ml) produced maximal inhibition, whereas IL-1 enhanced inhibition at submaximal TNF concentrations. The key to our model is that substrate input into the tricarboxylic acid cycle in the form of either alanine or pyruvate was required for cytokine mediated inhibition of fatty acid oxidation. Alanine or pyruvate may serve as a source for increased production of malonyl CoA, a potent inhibitor of fatty acid oxidation. We hypothesize that cytokines cause an inappropriate switch from fatty acid oxidation to fatty acid synthesis which has serious consequences for energy levels in the liver and can lead to end organ failure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7749930     DOI: 10.1097/00024382-199402000-00007

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  19 in total

Review 1.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

2.  Delayed ethanol elimination and enhanced susceptibility to ethanol-induced hepatosteatosis after liver resection.

Authors:  Xu Liu; Ayako Hakucho; Jinyao Liu; Tatsuya Fujimiya
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

3.  Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice.

Authors:  Kara L Kliewer; Jia-Yu Ke; Min Tian; Rachel M Cole; Rebecca R Andridge; Martha A Belury
Journal:  Cancer Biol Ther       Date:  2014-12-02       Impact factor: 4.742

Review 4.  Effect of ethanol on lipid metabolism.

Authors:  Min You; Gavin E Arteel
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

5.  Regulatory T cells suppress excessive lipid accumulation in alcoholic liver disease.

Authors:  Hongwu Wang; Ting Wu; Yaqi Wang; Xiaoyang Wan; Junying Qi; Lan Li; Xiaojing Wang; Xiaoping Luo; Qin Ning
Journal:  J Lipid Res       Date:  2019-02-21       Impact factor: 5.922

Review 6.  Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism.

Authors:  Juliane I Beier; Gavin E Arteel
Journal:  Exp Biol Med (Maywood)       Date:  2012-01

Review 7.  Alcoholic liver disease and hepatitis C: a frequently underestimated combination.

Authors:  Sebastian Mueller; Gunda Millonig; Helmut K Seitz
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

Review 8.  New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury.

Authors:  Gavin E Arteel
Journal:  J Gastroenterol Hepatol       Date:  2008-03       Impact factor: 4.029

Review 9.  Current experimental perspectives on the clinical progression of alcoholic liver disease.

Authors:  Katja Breitkopf; Laura E Nagy; Juliane I Beier; Sebastian Mueller; Honglei Weng; Steven Dooley
Journal:  Alcohol Clin Exp Res       Date:  2009-07-23       Impact factor: 3.455

10.  Psychosine-induced alterations in peroxisomes of twitcher mouse liver.

Authors:  Miguel Agustin Contreras; Ehtishamul Haq; Takuhiro Uto; Inderjit Singh; Avtar Kaur Singh
Journal:  Arch Biochem Biophys       Date:  2008-06-24       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.